Head-to-head · WeighScore
FORM (by GBY) vs Society of You
By GLP-1 ScorecardUpdated
Score comparison
Society of You has the higher recorded score — 62.4/100 to 58.6/100.
Society of You grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Society publishes injectable starting prices and a refund policy with a first-two-month restriction and a limited clinical-ineligibility exception.
Before you choose
Before comparing the headline prices, the FORM (by GBY) review and the Society of You review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, AgelessRx vs FORM (by GBY) and GetRelief Rx vs Society of You compare each of them with another graded program, and the list of alternatives to FORM (by GBY) ranks the programs closest to FORM (by GBY) on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the SkinnyRx review covers one graded close to these two, at 60.5/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | FORM (by GBY) | Society of You |
|---|---|---|
| WeighScore | 58.6/100 | 62.4/100 |
| Grade | C | C |
| Site position | #399 | #294 |
| Semaglutide | Stand-alone offer $99 first month, then $159; confirm selected quote | Advertised from $149; selected charge unverified |
| Tirzepatide | Stand-alone offer $169 first month, then $219; confirm selected quote | Advertised from $249; selected charge unverified |
| Coverage | Confirm availability for your state and selected treatment | Availability varies by state |
| Brand-name access | Yes | Not confirmed |
| Oral / sublingual | Yes | Not confirmed |
Strengths
- Publishes distinct first-month and continuing stand-alone prices
- Lists oral options and separate branded membership pathways
What to consider
- Confirm the selected formulation, supply and debit
- Unused subscription time is generally not refunded
Strengths
- Publishes injectable semaglutide and tirzepatide starting prices
- Public policy distinguishes future cancellations from processed charges
What to consider
- First and continuing charges are not verified for the selected plan
- First two months are described as nonrefundable, with a separate limited clinical-ineligibility clause
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.